UroGen Pharma

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell UroGen Pharma and other ETFs, options, and stocks.

About URGN

UroGen Pharma Ltd. is a biopharmaceutical company dedicated to building novel solutions that treat specialty cancers and urologic diseases. It has developed RTGel reverse-thermal hydrogel, a proprietary sustained release, hydrogel-based platform technology that has the potential to improve therapeutic profiles of existing drugs. 

CEO
Elizabeth Barrett
CEOElizabeth Barrett
Employees
195
Employees195
Headquarters
Princeton, New Jersey
HeadquartersPrinceton, New Jersey
Founded
2004
Founded2004
Employees
195
Employees195

URGN Key Statistics

Market cap
202.38M
Market cap202.38M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
59.27K
Average volume59.27K
High today
$8.90
High today$8.90
Low today
$8.33
Low today$8.33
Open price
$8.36
Open price$8.36
Volume
75.00K
Volume75.00K
52 Week high
$12.63
52 Week high$12.63
52 Week low
$4.85
52 Week low$4.85

Analyst ratings

83%

of 6 ratings
Buy
83.3%
Hold
16.7%
Sell
0%

URGN Earnings

-$1.35
-$0.90
-$0.45
$0.00
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Q4 FY22
Estimated
per share
Estimated per share
Actual
Expected Mar 21, Pre-Market
ActualExpected Mar 21, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.